Cyclobenzaprine vs Gabapentin
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Cyclobenzaprine (brand name Flexeril) and gabapentin (brand name Neurontin) are both commonly prescribed for pain-related conditions, but they target fundamentally different types of pain through distinct pharmacological mechanisms [1][2].
Cyclobenzaprine is a centrally acting skeletal muscle relaxant structurally related to tricyclic antidepressants [1]. It works by reducing muscle spasm through action at the brainstem rather than at the neuromuscular junction. It is FDA-approved for short-term use (2-3 weeks) as an adjunct to rest and physical therapy for acute musculoskeletal conditions involving painful muscle spasm [1].
Gabapentin is an anticonvulsant and analgesic that modulates calcium channels by binding to the alpha-2-delta subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release [2]. It is FDA-approved for postherpetic neuralgia (nerve pain after shingles) and as adjunctive therapy for partial seizures [2]. It is also widely used off-label for various neuropathic pain conditions, fibromyalgia, anxiety, and restless leg syndrome.
The key distinction is that cyclobenzaprine targets acute muscular pain and spasm, while gabapentin targets chronic nerve-related (neuropathic) pain [1][2].
Cyclobenzaprine vs Gabapentin: Side-by-side comparison
| Category | Cyclobenzaprine | Gabapentin |
|---|---|---|
| Drug Class | Skeletal muscle relaxant | Anticonvulsant / neuropathic analgesic |
| Brand Names | Flexeril, Amrix | Neurontin, Gralise |
| FDA-Approved Uses | Acute musculoskeletal pain/spasm (short-term) | Postherpetic neuralgia, partial seizures |
| Typical Dosage | 5-10 mg three times daily | 300-1200 mg three times daily |
| Duration of Use | 2-3 weeks maximum | Long-term (as needed) |
| Pain Type Targeted | Acute muscle spasm/pain | Neuropathic (nerve) pain |
| Common Side Effects | Drowsiness (39%), dry mouth (27%), dizziness | Somnolence (20%), dizziness (17%), edema |
| Anticholinergic Effects | Significant | Minimal |
| Controlled Substance | No | Schedule V in some states |
| Generic Cost (30-day) | $4-$10 | $4-$15 |
Efficacy: How well does each drug work?
For acute musculoskeletal pain with muscle spasm, cyclobenzaprine is more appropriate and has demonstrated efficacy in clinical trials showing improvement in local pain, muscle spasm, tenderness, and range of motion within 1-2 weeks of treatment [1][3]. It is not effective for chronic pain conditions or neuropathic pain.
For neuropathic pain (postherpetic neuralgia, diabetic neuropathy), gabapentin is the established treatment [2][4]. Randomized controlled trials have demonstrated significant pain reduction compared to placebo, with NNT (number needed to treat) values of approximately 6-8 for 50% pain reduction in postherpetic neuralgia [4]. Gabapentin has no role in treating acute muscle spasm.
For fibromyalgia, gabapentin has shown benefit in clinical trials and is used off-label, though pregabalin (its close relative) has the FDA approval for this indication [4]. Cyclobenzaprine at low doses (1-4 mg at bedtime) has been studied for fibromyalgia with some evidence of benefit for sleep quality, but evidence is limited [3].
For chronic low back pain, neither drug has strong evidence as a standalone treatment, though both are frequently prescribed off-label. Current guidelines emphasize non-pharmacological approaches and NSAIDs as first-line therapies [3].
Side effects comparison
Cyclobenzaprine's most common side effects include drowsiness (39%), dry mouth (27%), dizziness (11%), and fatigue [1]. Its anticholinergic properties (inherited from its tricyclic structure) can cause constipation, urinary retention, and blurred vision. It should be used cautiously in elderly patients due to fall risk and cognitive effects [1]. It is not recommended for use beyond 2-3 weeks. Cyclobenzaprine should not be combined with MAO inhibitors and should be used cautiously with serotonergic drugs due to serotonin syndrome risk [1].
Gabapentin's most common side effects include somnolence (20%), dizziness (17%), ataxia (13%), and peripheral edema [2]. It has minimal anticholinergic effects compared to cyclobenzaprine. Gabapentin requires gradual dose titration (over 1-2 weeks) and should not be abruptly discontinued due to risk of withdrawal seizures [2]. Recent FDA warnings have highlighted the risk of respiratory depression when combined with opioids or other CNS depressants [2]. Gabapentin has been reclassified as a Schedule V controlled substance in some states due to misuse concerns.
Both cause significant sedation, and patients should be cautioned about driving and operating machinery [1][2].
Cost comparison
Both are available as affordable generics [5]. Generic cyclobenzaprine (5 mg, 10 mg) costs $4-$10 for a 30-day supply. Generic gabapentin (100 mg, 300 mg, 400 mg, 600 mg, 800 mg) costs $4-$15 for a 30-day supply. Both qualify for $4 generic programs at most pharmacies.
Convenience and dosing
Cyclobenzaprine is typically dosed 5-10 mg three times daily for 2-3 weeks, with the option to use it only at bedtime to leverage its sedative effects while minimizing daytime drowsiness [1].
Gabapentin requires slow dose titration over 1-2 weeks, starting at 100-300 mg at bedtime and increasing to a therapeutic dose of 900-3600 mg/day divided into three doses [2]. The extended titration period means it takes longer to reach full benefit compared to cyclobenzaprine's faster onset.
Which is right for you?
Cyclobenzaprine is the appropriate choice for acute musculoskeletal conditions with muscle spasm, used as short-term adjunct therapy alongside rest, ice, and physical therapy [1][3]. It should not be used long-term or for neuropathic pain.
Gabapentin is the appropriate choice for neuropathic pain conditions (postherpetic neuralgia, diabetic neuropathy), seizure disorders, and off-label for conditions like restless legs syndrome and anxiety [2][4]. It is suitable for longer-term use under medical supervision.
This information is for educational purposes only and does not constitute medical advice. Consult your healthcare provider to determine which medication is appropriate for your type of pain.
Frequently asked questions
References
- [Regulatory] Flexeril (cyclobenzaprine HCl) prescribing information. McNeil. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017821s035lbl.pdf Accessed 2026-02-28.
- [Regulatory] Neurontin (gabapentin) prescribing information. Pfizer. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020235s075lbl.pdf Accessed 2026-02-28.
- [Regulatory] Qaseem A, et al. ACP clinical guideline for noninvasive treatments for acute, subacute, and chronic low back pain. Ann Intern Med. 2017;166(7):514-530. https://doi.org/10.7326/M16-2459 Accessed 2026-02-28.
- [Regulatory] Wiffen PJ, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017. https://doi.org/10.1002/14651858.CD007938.pub4 Accessed 2026-02-28.
- [Observational] GoodRx. Current pricing for generic cyclobenzaprine and gabapentin. https://www.goodrx.com/ Accessed 2026-02-28.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: